View : 792 Download: 0

Full metadata record

DC Field Value Language
dc.contributor.author오구택*
dc.date.accessioned2016-12-27T02:12:25Z-
dc.date.available2016-12-27T02:12:25Z-
dc.date.issued2016*
dc.identifier.issn1738-5520*
dc.identifier.otherOAK-19733*
dc.identifier.urihttps://dspace.ewha.ac.kr/handle/2015.oak/233155-
dc.description.abstractThe tumor necrosis factor receptor superfamily (TNFRSF), which includes CD40, LIGHT, and OX40, plays important roles in the initiation and progression of cardiovascular diseases, involving atherosclerosis. CD137, a member of TNFRSF, is a well-known activation-induced T cell co-stimulatory molecule and has been reported to be expressed in human atherosclerotic plaque lesions, and plays pivotal roles in mediating disease processes. In this review, we focus on and summarize recent advances in mouse studies on the involvement of CD137 signaling in the pathogenesis and plaque stability of atherosclerosis, thereby highlighting a valuable therapeutic target in atherosclerosis. Copyright © 2016 The Korean Society of Cardiology.*
dc.languageEnglish*
dc.publisherKorean Society of Circulation*
dc.subjectAtherosclerosis*
dc.subjectCD137*
dc.subjectPlaque stability*
dc.subjectT cell*
dc.titleThe roles of CD137 signaling in atherosclerosis*
dc.typeReview*
dc.relation.issue6*
dc.relation.volume46*
dc.relation.indexSCIE*
dc.relation.indexSCOPUS*
dc.relation.indexKCI*
dc.relation.startpage753*
dc.relation.lastpage761*
dc.relation.journaltitleKorean Circulation Journal*
dc.identifier.doi10.4070/kcj.2016.46.6.753*
dc.identifier.wosidWOS:000387737700002*
dc.identifier.scopusid2-s2.0-84994673844*
dc.author.googleJung I.-H.*
dc.author.googleOh G.T.*
dc.contributor.scopusid오구택(7007056663)*
dc.date.modifydate20240123094756*
Appears in Collections:
자연과학대학 > 생명과학전공 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

BROWSE